DSpace Repository

Management of relapsing-remitting multiple sclerosis in Latin America: practical recommendations for treatment optimization

Show simple item record

dc.contributor.author Correale, Jorge
dc.contributor.author Abad, Patricio
dc.contributor.author Alvarenga, Regina
dc.contributor.author Alves-Leon, Soniza
dc.contributor.author Armas, Elizabeth
dc.contributor.author Barahona, Jorge
dc.contributor.author Buzo, Ricardo
dc.contributor.author Corona, Teresa
dc.contributor.author Cristiano, Edgardo
dc.contributor.author Gracia, Fernando
dc.contributor.author Bonitto, Juan Garcia
dc.contributor.author Macias, Miguel Angel
dc.contributor.author Soto, Arnoldo
dc.contributor.author Vizcarra, Darwin
dc.contributor.author Freedman, Mark S.
dc.date.accessioned 2020-06-10T18:12:13Z
dc.date.available 2020-06-10T18:12:13Z
dc.date.issued 2014
dc.identifier.uri https://hdl.handle.net/20.500.12866/8057
dc.description.abstract The Latin American MS Experts' Forum has developed practical recommendations on the initiation and optimization of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis (RRMS). The recommendations reflect the unique epidemiology of MS and the clinical practice environment in Latin American countries. Treatment response may be evaluated according to changes in relapses; progression, as assessed by the Expanded Disability Status Scale and the Timed 25-foot Walk; and lesion number on magnetic resonance imaging. Follow-up assessments are recommended every six months, or annually for stable patients. Cognitive function should be evaluated in all RRMS patients at baseline and annually thereafter. These recommendations are intended to assist clinicians in Latin America in developing a rational approach to treatment selection and sequencing for their RRMS patients. en_US
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartof urn:issn:1878-5883
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Disease Management en_US
dc.subject Algorithm en_US
dc.subject Clinical recommendations en_US
dc.subject Disability en_US
dc.subject Humans en_US
dc.subject Immunosuppressive Agents/therapeutic use en_US
dc.subject Interferon-beta/therapeutic use en_US
dc.subject Latin America en_US
dc.subject Latin America/epidemiology en_US
dc.subject Mitoxantrone/therapeutic use en_US
dc.subject MRI en_US
dc.subject Multiple sclerosis en_US
dc.subject Multiple Sclerosis, Relapsing-Remitting/diagnosis/epidemiology/therapy en_US
dc.subject Practice Guidelines as Topic/standards en_US
dc.subject Relapses en_US
dc.subject Treatment en_US
dc.subject Treatment Outcome en_US
dc.subject Vitamin D/therapeutic use en_US
dc.title Management of relapsing-remitting multiple sclerosis in Latin America: practical recommendations for treatment optimization en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1016/j.jns.2014.02.017
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.00 es_PE
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.25

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/restrictedAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/restrictedAccess

Search DSpace


My Account